These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

183 related articles for article (PubMed ID: 29719204)

  • 21. Pharmacological treatments for opiate and alcohol addiction: A historical perspective of the last 50 years.
    Blanco-Gandía MC; Rodríguez-Arias M
    Eur J Pharmacol; 2018 Oct; 836():89-101. PubMed ID: 30096298
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Potential medications for the treatment of alcohol use disorder: An evaluation of clinical efficacy and safety.
    Litten RZ; Wilford BB; Falk DE; Ryan ML; Fertig JB
    Subst Abus; 2016; 37(2):286-98. PubMed ID: 26928397
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Anticraving therapy for alcohol use disorder: A clinical review.
    Shen WW
    Neuropsychopharmacol Rep; 2018 Sep; 38(3):105-116. PubMed ID: 30175522
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Alcohol Use Disorder: The Role of Medication in Recovery.
    Mason BJ; Heyser CJ
    Alcohol Res; 2021; 41(1):07. PubMed ID: 34113531
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Benzodiazepines in the treatment of alcoholism].
    Ades J; Rodière C
    Encephale; 1983; 9(4 Suppl 2):293B-298B. PubMed ID: 6373235
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Efficacy of Medications Approved for the Treatment of Alcohol Dependence and Alcohol Withdrawal Syndrome in Female Patients: A Descriptive Review.
    Agabio R; Pani PP; Preti A; Gessa GL; Franconi F
    Eur Addict Res; 2016; 22(1):1-16. PubMed ID: 26314552
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Pharmacotherapy of alcohol dependence: a review of the clinical data.
    Mann K
    CNS Drugs; 2004; 18(8):485-504. PubMed ID: 15182219
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Pharmacotherapy for Substance Use Disorders.
    Klein JW
    Med Clin North Am; 2016 Jul; 100(4):891-910. PubMed ID: 27235620
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Sodium oxybate in the treatment of alcohol dependence: from the alcohol withdrawal syndrome to the alcohol relapse prevention.
    Skala K; Caputo F; Mirijello A; Vassallo G; Antonelli M; Ferrulli A; Walter H; Lesch O; Addolorato G
    Expert Opin Pharmacother; 2014 Feb; 15(2):245-57. PubMed ID: 24283802
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Opioid Receptor Antagonists in the Treatment of Alcoholism.
    Serecigni JG
    Adicciones; 2015 Sep; 27(3):214-30. PubMed ID: 26437315
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Sodium oxybate plus nalmefene for the treatment of alcohol use disorder: A case series.
    Caputo F; Maremmani AG; Addolorato G; Domenicali M; Zoli G; D'Amore A; Maremmani I; Bernardi M
    J Psychopharmacol; 2016 Apr; 30(4):402-9. PubMed ID: 26860331
    [TBL] [Abstract][Full Text] [Related]  

  • 32. A pharmacokinetic and pharmacodynamic drug interaction study of acamprosate and naltrexone.
    Mason BJ; Goodman AM; Dixon RM; Hameed MH; Hulot T; Wesnes K; Hunter JA; Boyeson MG
    Neuropsychopharmacology; 2002 Oct; 27(4):596-606. PubMed ID: 12377396
    [TBL] [Abstract][Full Text] [Related]  

  • 33. A Brief Up-Date of the Use of Sodium Oxybate for the Treatment of Alcohol Use Disorder.
    Caputo F; Vignoli T; Tarli C; Domenicali M; Zoli G; Bernardi M; Addolorato G
    Int J Environ Res Public Health; 2016 Mar; 13(3):. PubMed ID: 26959045
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Pharmacotherapy of alcohol use disorders.
    Buonopane A; Petrakis IL
    Subst Use Misuse; 2005; 40(13-14):2001-20, 2043-8. PubMed ID: 16282090
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Alcohol--mechanism of action, interactions and treatment of alcohol abuse].
    Korpi E; Seppälä T
    Duodecim; 1998; 114(10):1029-36. PubMed ID: 11524777
    [No Abstract]   [Full Text] [Related]  

  • 36. Acamprosate for the treatment of alcohol dependence.
    Boothby LA; Doering PL
    Clin Ther; 2005 Jun; 27(6):695-714. PubMed ID: 16117977
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Post-marketing and clinical safety experience with sodium oxybate for the treatment of alcohol withdrawal syndrome and maintenance of abstinence in alcohol-dependent subjects.
    Addolorato G; Lesch OM; Maremmani I; Walter H; Nava F; Raffaillac Q; Caputo F
    Expert Opin Drug Saf; 2020 Feb; 19(2):159-166. PubMed ID: 31876433
    [No Abstract]   [Full Text] [Related]  

  • 38. Naltrexone and disulfiram in patients with alcohol dependence and current depression.
    Petrakis I; Ralevski E; Nich C; Levinson C; Carroll K; Poling J; Rounsaville B;
    J Clin Psychopharmacol; 2007 Apr; 27(2):160-5. PubMed ID: 17414239
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Treatment-refractory substance use disorder: Focus on alcohol, opioids, and cocaine.
    Soyka M; Mutschler J
    Prog Neuropsychopharmacol Biol Psychiatry; 2016 Oct; 70():148-61. PubMed ID: 26577297
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Pharmacotherapy for alcohol dependence: status of current treatments.
    Franck J; Jayaram-Lindström N
    Curr Opin Neurobiol; 2013 Aug; 23(4):692-9. PubMed ID: 23810221
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.